AI Analysis AI Analysis of GLAXF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GLAXF to Watchlist?
Some Reasons Why To Add GLAXF:
  • Beat earnings estimates in all of the last 4 quarters
  • Excellent financial health (Piotroski 7/9)
  • High gross margin of 72.7%
PDF

GlaxoSmithKline plc stock downgraded from Hold/Accumulate to Sell Candidate after Monday trading session
(Updated on Jun 22, 2026)

Sell candidate since Jun 22, 2026

No changes to the price of GlaxoSmithKline plc stock on the last trading day (Monday, 22nd Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $25.70 to a day high of $25.70. The price has been going up and down for this period, and there has been a 4.2% gain for the last 2 weeks.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.80% during the next 3 months and, with a 90% probability hold a price between $20.43 and $24.32 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GLAXF Signals & Forecast

The GlaxoSmithKline plc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $25.95. On a fall, the stock will find some support from the long-term average at approximately $25.46. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for GlaxoSmithKline plc stock

GlaxoSmithKline plc finds support from accumulated volume at $25.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 1.42%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GLAXF) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect GlaxoSmithKline plc to open at $25.70, and during the day (based on 14 day Average True Range), to move between $25.43 and $25.97, which gives a possible trading interval of +/-$0.531 (+/-2.09%) up or down from last closing price. If GlaxoSmithKline plc takes out the full calculated possible swing range there will be an estimated 2.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $26.03 (1.28%) than the support at $25.12 (2.27%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is GlaxoSmithKline plc stock A Buy?

GlaxoSmithKline plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.094 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $25.70 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GLAXF Performance

Trading levels for GLAXF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 25.70 -
R2 25.70 -
R1 25.70 -
Price 25.70
S1 25.70 -
S2 25.70 -
S3 25.70 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 26.75 4.09%
R2 26.24 2.08%
R1 26.03 1.28%
Price 25.70
S1 25.12 -2.27%
S2 25.01 -2.68%
S3 24.66 -4.03%

GLAXF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Nov 10, 2025 May 15, 2026 Jul 09, 2026 $0.227 0.88%
2 May 14, 2026 May 14, 2026 Jul 09, 2026 $0.229 0.88%
3 Nov 11, 2024 Feb 20, 2026 Apr 09, 2026 $0.246 0.81%
4 Feb 19, 2026 Feb 19, 2026 Apr 09, 2026 $0.246 0.84%
5 Nov 11, 2024 Nov 14, 2025 Jan 08, 2026 $0.206 0.94%

FAQ

What is the symbol for GlaxoSmithKline plc Stock and on which exchange is it traded?
The symbol for GlaxoSmithKline plc is GLAXF and it is traded on the PINK (Pink Sheets).

Should I buy or sell GlaxoSmithKline plc Stock?
GlaxoSmithKline plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy GlaxoSmithKline plc Stock?
GlaxoSmithKline plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GlaxoSmithKline plc Stock.

What's the current price of GlaxoSmithKline plc Stock?
As of the end of day on the Jun 22, 2026, the price of an GlaxoSmithKline plc (GLAXF) share was $25.70.

What is the 52-week high and low for GlaxoSmithKline plc Stock?
The 52-week high for GlaxoSmithKline plc Stock is $31.48 and the 52-week low is $17.15.

What is the market capitalization of GlaxoSmithKline plc Stock?
As of the Jun 22, 2026, the market capitalization of GlaxoSmithKline plc is 102.999B.

When is the next earnings date for GlaxoSmithKline plc?
The upcoming earnings date for GlaxoSmithKline plc is Jul 28, 2026.
Click to get the best stock tips daily for free!
ABOUT GLAXOSMITHKLINE PLC
GlaxoSmithKline
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medic...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE